Medipost Holdings appoints new CEO

The new CEO of Medipost Holdings, Mziwandile Noel Guliwe

Mziwandile Noel Guliwe, who is known for successfully introducing generic medicines to the domestic market, has been appointed CEO of Medipost Holdings.

“Over his illustrious career, Noel Guliwe has become one of the leading figures within the country’s healthcare landscape. He is ideally placed to take Medipost Holdings to new levels of prosperity as we serve the medical professionals, patients and wholesalers who rely on our services,” says Mamedupi Matsipa, chairperson of Medipost Holdings. “We also believe his strong relationships within the greater healthcare and pharmaceutical industries will stand the group and its clients in excellent stead.”

“With over a quarter of a century’s experience in the South African pharmaceutical industry, Guliwe brings with him a wealth of knowledge and understanding of the landscape in which the Medipost Pharmacy, MediLogistics, Kawari Wholesalers and Medi Training Academy brands operate,” she noted.

Guliwe joins Medipost Holdings from his previous post at Aspen Pharmacare, where he served as chief executive officer of the company’s South African operations for almost a decade.

Guliwe has served as chairperson of Innovative Medicines South Africa and as Pharma forum stakeholder leader on the Healthcare Charter negotiations and is a former member of the Medicine Control Council (MCC) Appeals Committee.

“The Board of Medipost Holdings is looking forward to Guliwe’s valuable contribution and takes great pleasure in welcoming him to the Group. We wish him every success in his new role,” concluded Matsipa.